Granulosa cell tumour: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 39: Line 39:
[[Granulosa cell tumour medical therapy|Medical Therapy]] | [[Granulosa cell tumour surgery|Surgery]] | [[Granulosa cell tumour primary prevention|Primary Prevention]] | [[Granulosa cell tumour secondary prevention|Secondary Prevention]] | [[Granulosa cell tumour cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Granulosa cell tumour future or investigational therapies|Future or Investigational Therapies]]
[[Granulosa cell tumour medical therapy|Medical Therapy]] | [[Granulosa cell tumour surgery|Surgery]] | [[Granulosa cell tumour primary prevention|Primary Prevention]] | [[Granulosa cell tumour secondary prevention|Secondary Prevention]] | [[Granulosa cell tumour cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Granulosa cell tumour future or investigational therapies|Future or Investigational Therapies]]


==See also==
==Related chapters==
* [[granulosa cell]]
* [[granulosa cell]]
* [[Sertoli-Leydig cell tumour]]
* [[Sertoli-Leydig cell tumour]]
Line 45: Line 45:
{{Epithelial neoplasms}}
{{Epithelial neoplasms}}


[[Category:Disease]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]

Revision as of 04:28, 22 January 2012